ProCE Banner Activity

Current Immunotherapy Options for Advanced HCC and Expert Answers to Clinician Questions: Podcast Pearls

PDF
In this downloadable PDF transcript from a CCO podcast, David Kaplan, MD, MSc, and Thomas Karasic, MD, discuss HCP questions focused on current best practices with immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma.

Released: June 29, 2021

Expiration: June 28, 2022

No longer available for credit.

Share

Faculty

David Kaplan

David Kaplan, MD, MSc

Assistant Professor of Medicine
Division of Gastroenterology
University of Pennsylvania Perelman School of Medicine
Director of Hepatology
Gastroenterology Section
Philadelphia VA Medical Center
Philadelphia, Pennsylvania

Thomas B. Karasic

Thomas B. Karasic, MD

Physician Leader, Developmental Therapeutics
Assistant Professor of Medicine
Division of Hematology-Oncology
University of Pennsylvania
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Genentech, a member of the Roche Group

Faculty Disclosure

Primary Author

David Kaplan, MD, MSc

Assistant Professor of Medicine
Division of Gastroenterology
University of Pennsylvania Perelman School of Medicine
Director of Hepatology
Gastroenterology Section
Philadelphia VA Medical Center
Philadelphia, Pennsylvania

Thomas B. Karasic, MD

Physician Leader, Developmental Therapeutics
Assistant Professor of Medicine
Division of Hematology-Oncology
University of Pennsylvania
Philadelphia, Pennsylvania